Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study-Reference-Cited by-同舟云学术

Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort study

Published:2020-01 Issue:1 Volume:2 Page:e24-e30
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Apostolopoulos Diane,Kandane-Rathnayake Rangi,Louthrenoo Worawit,Luo Shue Fen,Wu Yeong-Jian,Lateef Aisha,Golder Vera,Sockalingam Sargunan,Navarra Sandra,Zamora Leonid,Hamijoyo Laniyati,Katsumata Yasuhiro,Harigai Masayoshi,Chan Madelynn,O'Neill Sean,Goldblatt Fiona,Lau Chak Sing,Li Zhan Guo,Hoi Alberta,Nikpour Mandy,Morand Eric

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference26 articles.

1. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force;van Vollenhoven;Ann Rheum Dis,2014

2. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus;Gladman;Arthritis Rheum,1996

3. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus;Rivest;J Rheumatol,2000

4. Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort;Bruce;Ann Rheum Dis,2015

5. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden;Danchenko;Lupus,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic glucocorticoid therapy for SLE;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Treatment patterns in patients with systemic lupus erythematosus in New Zealand;Lupus;2024-08-16

3. Addressing the research gap: access to care hinders genetic discovery in systemic lupus erythematosus patients throughout the African diaspora;Frontiers in Genetics;2024-08-15

4. Die 2023 EULAR-Empfehlungen zur Behandlung des systemischen Lupus erythematodes – Implikationen für die Versorgung in Deutschland;Zeitschrift für Rheumatologie;2024-07-22

5. Real-world effectiveness of belimumab in patients with lupus in China: RELIABLE observational cohort study protocol;Lupus Science & Medicine;2024-07